F-group (family)
2006.1.1.10 NT5C
Ligands and drugs
74
Member domains
36
with ligand contacts (≤ 4 Å)
48.6% of members
33
with DrugDomain annotations
44.6% of members
28
with a DrugBank compound
37.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2006.1.1.10 belongs to X-group 2006 HAD domain-like, which binds 9.7 ligand superclasses per 20 proteins, broader than 91% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03345 | BME | Mercaptoethanol | 3 |
| DB02256 | DUR | 2'-Deoxyuridine | 2 |
| DB03800 | UMP | Deoxyuridine monophosphate | 2 |
| DB04444 | ALF | Tetrafluoroaluminate Ion | 2 |
| DB04457 | DGP | 2'-Deoxyguanosine-5'-Monophosphate | 2 |
| DB01643 | TMP | Thymidine monophosphate | 1 |
| DB02217 | DPB | Dpb-T | 1 |
| DB03666 | ATM | Zidovudine monophosphate | 1 |
| DB03685 | U5P | Uridine monophosphate | 1 |
| DB04438 | BVP | Brivudine monophosphate | 1 |
| DB04672 | D4M | Cyclic 3',5'-thymidine monophosphate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 33 |
| 2O2 | 1-{2-deoxy-3,5-O-[phenyl(phosphono)methylidene]-beta-D-threo-pentofuranosyl}-5-[(E)-2-phosphonoethenyl]pyrimidine-2,4(1H,3H)-dione | 4 |
| BME | BETA-MERCAPTOETHANOL | 3 |
| Kmetal | POTASSIUM ION | 3 |
| O84 | [(2~{R},4~{a}~{R},6~{R},7~{a}~{R})-6-[2,4-bis(oxidanylidene)-5-[(~{E})-3-phosphonoprop-1-enyl]pyrimidin-1-yl]-2-phenyl-4~{a},6,7,7~{a}-tetrahydro-4~{H}-furo[3,2-d][1,3]dioxin-2-yl]phosphonic acid | 3 |
| ALF | TETRAFLUOROALUMINATE ION | 2 |
| CL | CHLORIDE ION | 2 |
| DGP | 2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE | 2 |
| DUR | 2'-DEOXYURIDINE | 2 |
| NAmetal | SODIUM ION | 2 |
| UMP | 2'-DEOXYURIDINE 5'-MONOPHOSPHATE | 2 |
| 0BT | 1-{2-deoxy-3,5-O-[(4-iodophenyl)(phosphono)methylidene]-beta-D-threo-pentofuranosyl}-5-methylpyrimidine-2,4(1H,3H)-dione | 1 |
| 2E2 | 1-{3,5-O-[(4-carboxyphenyl)(phosphono)methylidene]-2-deoxy-beta-D-threo-pentofuranosyl}-5-methylpyrimidine-2,4(1H,3H)-dione | 1 |
| 2JW | 1-{2-deoxy-3,5-O-[(4-nitrophenyl)(phosphono)methylidene]-beta-D-threo-pentofuranosyl}-5-methylpyrimidine-2,4(1H,3H)-dione | 1 |
| ATM | 3'-AZIDO-3'-DEOXYTHYMIDINE-5'-MONOPHOSPHATE | 1 |
| BVP | (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE-5'-MONOPHOSPHATE | 1 |
| D4M | [(5R)-5-(5-METHYL-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-2,5-DIHYDROFURAN-2-YL]METHYL DIHYDROGEN PHOSPHATE | 1 |
| DPB | (S)-1-[2'-DEOXY-3',5'-O-(1-PHOSPHONO)BENZYLIDENE-B-D-THREO-PENTOFURANOSYL]THYMINE | 1 |
| DRM | {[(1R,2S)-2-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)CYCLOPENTYL]OXY}METHYLPHOSPHONIC ACID | 1 |
| EJ8 | [(2~{R},4~{a}~{R},6~{R},7~{a}~{R})-6-[2,4-bis(oxidanylidene)-5-(phosphonomethylsulfanylmethyl)pyrimidin-1-yl]-2-phenyl-4~{a},6,7,7~{a}-tetrahydro-4~{H}-furo[3,2-d][1,3]dioxin-2-yl]phosphonic acid | 1 |